BGR GOVERNMENT AFFAIRS

Lobbying for PTC THERAPEUTICS · Biopharmaceutical

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · New Jersey · House · Senate · $50,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

Provide guidance and advocacy with regard to regulations and legislation that could impact the pharmaceutical industry generally, and PTC specifically.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.